Biotech Growth Investors & VC Firms

747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
OX Oxford Investment Consultants LLP GRPLRHCH11 people	88🔒	Oxford	GB	Seed–Late Stage	—	+ Add to CRM
DE Deep Insight BBEKIKNC6 people	88🔒	Tel Aviv	IL	Pre-Seed–Late Stage	—	+ Add to CRM
TU TusStar	88🔒	Beijing	CN	Pre-Seed–Growth	—	+ Add to CRM
AI AI Capital JSNTECSS11 people	88🔒	Denver	US	Series A–Growth	—	+ Add to CRM
GE Georgian APEWEKFS11 people	88🔒	Toronto, Ontario	CA	Series B–Late Stage	$25M – $100M	+ Add to CRM
IN Incentive, Peregrine Ventures Incubator BLELLSD(11 people	88🔒	Israel	IL	Pre-Seed–Growth	—	+ Add to CRM
OC OCV Partners RRALCBHZ5 people · Leads rounds	88🔒	Los Angeles	US	Pre-Seed–Late Stage	—	+ Add to CRM
TE Tenacity Ventures GBRRKRRA5 people · Leads rounds	88🔒	Bengaluru	IN	Seed–Growth	$10M	+ Add to CRM
VE Vesalius Biocapital Partners APCSGMSV5 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M	+ Add to CRM
KO Kolon Investment, Inc.	88🔒	Seoul	KR	Seed–Late Stage	$3K – $22M	+ Add to CRM
SH Shenzhen Capital Group DZSLXW3 people	88🔒	Shenzhen	CN	Seed–Growth	$1.5M – $156M	+ Add to CRM
PA Panakes Partners ABDSFLBC11 people · Follows rounds	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
YZ YZR Capital MFRMHEMS11 people	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
IN iNetworks ALAJMDGM9 people	88🔒	Pittsburgh	US	Seed–Late Stage	—	+ Add to CRM
KI KIC Ventures KRAHVLAW9 people	88🔒	Fort Lauderdale	US	Seed–Late Stage	—	+ Add to CRM
AC Access Biotechnology LRCB2 people · Leads rounds	88🔒	New York City	US	Seed–Late Stage	—	+ Add to CRM
BR Bridge to Growth GGMBSSFW4 people	88🔒	Berlin	DE	Series A–Late Stage	$1.1M – $5.4M	+ Add to CRM
DE Development Capital ABSHACFS7 people	88🔒	Dublin	IE	Growth	$2.2M – $13.2M	+ Add to CRM
RO Roche Venture Fund AHDESGCN6 people	88🔒	Basel	CH	Seed–Growth	$648K – $3.2M	+ Add to CRM
CL Clal Biotechnology Industries AALNAFBG8 people	88🔒	Tel Aviv	IL	Seed–Late Stage	—	+ Add to CRM
JS JSD Capital, LLC JMJSAHGM8 people	88🔒	New York	US	Seed–Late Stage	$10M	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Seed–Late Stage	$5M – $15M	+ Add to CRM
AV Avant Bio DKSLLUMW7 people · Leads rounds	88🔒	New York	US	Seed–Growth	—	+ Add to CRM

Oxford Investment Consultants LLP

OxfordSeed–Late Stage

GRPLRHCH11 people

Deep Insight

Tel AvivPre-Seed–Late Stage

BBEKIKNC6 people

TusStar

BeijingPre-Seed–Growth

AI Capital

DenverSeries A–Growth

JSNTECSS11 people

Georgian

Toronto, OntarioSeries B–Late Stage$25M – $100M

APEWEKFS11 people

Incentive, Peregrine Ventures Incubator

IsraelPre-Seed–Growth

BLELLSD(11 people

OCV Partners

Los AngelesPre-Seed–Late Stage

RRALCBHZ5 people

Tenacity Ventures

BengaluruSeed–Growth$10M

GBRRKRRA5 people

Vesalius Biocapital Partners

LuxembourgSeed–Late Stage$11M

APCSGMSV5 people

Kolon Investment, Inc.

SeoulSeed–Late Stage$3K – $22M

Shenzhen Capital Group

ShenzhenSeed–Growth$1.5M – $156M

DZSLXW3 people

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

YZR Capital

MunichPre-Seed–Growth

MFRMHEMS11 people

iNetworks

PittsburghSeed–Late Stage

ALAJMDGM9 people

KIC Ventures

Fort LauderdaleSeed–Late Stage

KRAHVLAW9 people

Access Biotechnology

New York CitySeed–Late Stage

LRCB2 people

Bridge to Growth

BerlinSeries A–Late Stage$1.1M – $5.4M

GGMBSSFW4 people

Development Capital

DublinGrowth$2.2M – $13.2M

ABSHACFS7 people

Roche Venture Fund

BaselSeed–Growth$648K – $3.2M

AHDESGCN6 people

Clal Biotechnology Industries

Tel AvivSeed–Late Stage

AALNAFBG8 people

JSD Capital, LLC

New YorkSeed–Late Stage$10M

JMJSAHGM8 people

Kern Capital, LLC

LarkspurSeed–Late Stage$5M – $15M

JK1 person

Avant Bio

New YorkSeed–Growth

DKSLLUMW7 people

Data sourced from public filings and firms' own websites — see our methodology.